查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1591868

荷尔蒙避孕药市场：按荷尔蒙、避孕方法和最终用户划分 - 全球预测 2025-2030

Hormonal Contraceptives Market by Hormone (Androgens, Antiandrogens, Estrogens), Method (Combined Oral Contraceptives, Implanted Contraceptives, Injected Contraceptives), End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年荷尔蒙避孕药市值为171.9亿美元，预计到2024年将达到183.4亿美元，复合年增长率为6.76%，到2030年将达到271.9亿美元。

荷尔蒙避孕药的市场范围包括透过调节女性体内荷尔蒙水平来预防怀孕的各种方法。这包括口服药、注射、贴片、避孕环、植入等。虽然荷尔蒙避孕药主要用于避孕，但它们也有调节月经週期、控制卵巢症候群 (PCOS) 等疾病和减少痤疮等益处。最终用途涵盖私人消费者和医疗机构。市场成长的推动因素包括计划生育意识的提高、月经相关疾病盛行率的上升以及对现代避孕方法的接受程度的提高。新的商机存在于避孕教育和服务需求未满足的领域，以及开发可最大限度减少副作用的先进分娩系统。专注于非侵入性避孕药和长效避孕药等创新的公司有潜力占领重要的市场占有率。然而，挑战包括文化和宗教的反对、持续使用的需要、与荷尔蒙方法相关的副作用以及来自非荷尔蒙替代品的竞争。监管障碍也会推迟产品发布并影响市场动态。限制因素包括低收入地区的价格敏感度以及影响可用性和核准的国家政策差异。个人化医疗和基因分析等技术进步提供了创新途径，透过优化荷尔蒙剂量实现有针对性的避孕解决方案，从而提高疗效并减少副作用。市场可以从对人口趋势、消费行为和客製化行销策略的洞察中受益。荷尔蒙避孕市场的竞争性和不断发展的性质要求公司能够对不断变化的消费者偏好和科学开拓做出快速反应。在负担能力、可及性和关于荷尔蒙避孕的优点和缺点的全面教育宣传活动之间保持平衡对于可持续增长至关重要。

主要市场统计
基准年[2023] 171.9亿美元
预测年份 [2024] 183.4亿美元
预测年份 [2030] 271.9亿美元
复合年增长率（%） 6.76%

市场动态：揭示快速发展的荷尔蒙避孕药市场的关键市场洞察

供需的动态交互作用正在改变荷尔蒙避孕市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 女性怀孕相关健康风险案例增加
    • 政府努力促进避孕药具的使用
    • 线上提供口服避孕药
  • 市场限制因素
    • 荷尔蒙避孕药的副作用
  • 市场机会
    • 研究创造高效避孕方法
    • 改善荷尔蒙避孕药的广告和行销
  • 市场问题
    • 社会对荷尔蒙避孕药的接受度有限

波特的五力：驾驭荷尔蒙避孕市场的策略工具

波特的五力框架是了解荷尔蒙避孕药市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解荷尔蒙避孕药市场的外部影响

外部宏观环境因素在塑造荷尔蒙避孕药市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解荷尔蒙避孕药市场的竞争格局

对荷尔蒙避孕药市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：荷尔蒙避孕药市场供应商的绩效评估

FPNV定位矩阵是评估荷尔蒙避孕药市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製荷尔蒙避孕药市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对荷尔蒙避孕药市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 与怀孕相关的女性健康风险增加
      • 政府努力促进避孕器的使用
      • 在线购买口服避孕药
    • 抑制因素
      • 荷尔蒙避孕药的副作用
    • 机会
      • 研究开发高效避孕方法
      • 改善荷尔蒙避孕药的广告和行销
    • 任务
      • 社会对荷尔蒙避孕药的接受度有限
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章 荷尔蒙避孕药市场：依荷尔蒙分类

  • 介绍
  • 雄激素
  • 抗雄激素
  • 雌激素
  • 促性腺激素分泌
  • 黄体素

第七章 荷尔蒙避孕药市场：依避孕方法分类

  • 介绍
  • 复方口服避孕药
  • 植入式避孕器
  • 注射避孕
  • 在子宫内
  • 口服避孕药
  • 经皮吸收贴片
  • 避孕环

第八章荷尔蒙避孕药市场：依最终用户分类

  • 介绍
  • 门诊手术中心
  • 妇科中心
  • 居家医疗
  • 医院/诊所

第九章美洲激素避孕药市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区荷尔蒙避孕药市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的荷尔蒙避孕市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Afaxys Pharma, LLC
  • Agile Therapeutics
  • Amgen Inc.
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Cipla Limited
  • Glenmark Pharmaceuticals Limited
  • HLL Lifecare Limited
  • Johnson & Johnson Services, Inc.
  • Lupin Pharmaceuticals, Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Piramal Group
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-4103B31E0668

The Hormonal Contraceptives Market was valued at USD 17.19 billion in 2023, expected to reach USD 18.34 billion in 2024, and is projected to grow at a CAGR of 6.76%, to USD 27.19 billion by 2030.

The scope of the market for hormonal contraceptives encompasses various methods to prevent pregnancy by modulating hormone levels in the female body. This includes oral pills, injections, patches, vaginal rings, and implants. The application of hormonal contraceptives primarily targets birth control, but also offers benefits such as regulating menstrual cycles, managing conditions like polycystic ovary syndrome (PCOS), and reducing acne. End-use scope spans across individual consumers and healthcare facilities. Market growth is fuelled by increasing awareness of family planning, rising prevalence of menstrual-related disorders, and growing acceptance of modern contraceptive methods. Emerging opportunities lie in regions with unmet needs for contraceptive education and services, as well as in developing advanced delivery systems that minimize side effects. Companies focusing on innovation, such as non-invasive contraceptives and those with extended duration of effectiveness, could capture significant market share. Meanwhile, challenges include cultural and religious opposition, the need for consistent usage, side effects associated with hormonal methods, and competition from non-hormonal alternatives. Regulatory hurdles can also delay product launches and affect market dynamics. Limiting factors might involve price sensitivity in low-income regions and varying national policies affecting availability and approval. Technological advancements like personalized medicine and genetic profiling offer avenues for innovation, enabling targeted contraceptive solutions with optimized hormonal dosages, thereby improving effectiveness and reducing side effects. The market can benefit from insights into demographic trends, consumer behavior, and tailored marketing strategies. The nature of the hormonal contraceptives market is competitive and fast-evolving, requiring businesses to adapt rapidly to changing consumer preferences and scientific developments. Maintaining a balance between affordability, accessibility, and comprehensive educational campaigns about the benefits and drawbacks of hormonal contraception is crucial for sustainable growth.

KEY MARKET STATISTICS
Base Year [2023] USD 17.19 billion
Estimated Year [2024] USD 18.34 billion
Forecast Year [2030] USD 27.19 billion
CAGR (%) 6.76%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hormonal Contraceptives Market

The Hormonal Contraceptives Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing cases of pregnancy-related health risks in women
    • Government initiatives to promote the use of contraceptives
    • Availability of oral contraceptives online
  • Market Restraints
    • Side effects of hormonal contraceptives
  • Market Opportunities
    • Research studies for producing highly effective contraceptive methods
    • Improving advertisements and marketing of hormonal contraceptives
  • Market Challenges
    • Limited social acceptance of hormonal contraceptives

Porter's Five Forces: A Strategic Tool for Navigating the Hormonal Contraceptives Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hormonal Contraceptives Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hormonal Contraceptives Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hormonal Contraceptives Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hormonal Contraceptives Market

A detailed market share analysis in the Hormonal Contraceptives Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hormonal Contraceptives Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hormonal Contraceptives Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hormonal Contraceptives Market

A strategic analysis of the Hormonal Contraceptives Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hormonal Contraceptives Market, highlighting leading vendors and their innovative profiles. These include Afaxys Pharma, LLC, Agile Therapeutics, Amgen Inc., Bayer AG, Boehringer Ingelheim GmbH, Cipla Limited, Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson Services, Inc., Lupin Pharmaceuticals, Inc., Novartis AG, Pfizer, Inc., Piramal Group, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Hormonal Contraceptives Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Hormone, market is studied across Androgens, Antiandrogens, Estrogens, Gonadotropins, and Progestogens.
  • Based on Method, market is studied across Combined Oral Contraceptives, Implanted Contraceptives, Injected Contraceptives, Intrauterine, Oral Contraceptives, Transdermal Patch, and Vaginal Ring.
  • Based on End-user, market is studied across Ambulatory Surgical Centers, Gynecology Centers, Homecare, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of pregnancy-related health risks in women
      • 5.1.1.2. Government initiatives to promote the use of contraceptives
      • 5.1.1.3. Availability of oral contraceptives online
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects of hormonal contraceptives
    • 5.1.3. Opportunities
      • 5.1.3.1. Research studies for producing highly effective contraceptive methods
      • 5.1.3.2. Improving advertisements and marketing of hormonal contraceptives
    • 5.1.4. Challenges
      • 5.1.4.1. Limited social acceptance of hormonal contraceptives
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Hormonal Contraceptives Market, by Hormone

  • 6.1. Introduction
  • 6.2. Androgens
  • 6.3. Antiandrogens
  • 6.4. Estrogens
  • 6.5. Gonadotropins
  • 6.6. Progestogens

7. Hormonal Contraceptives Market, by Method

  • 7.1. Introduction
  • 7.2. Combined Oral Contraceptives
  • 7.3. Implanted Contraceptives
  • 7.4. Injected Contraceptives
  • 7.5. Intrauterine
  • 7.6. Oral Contraceptives
  • 7.7. Transdermal Patch
  • 7.8. Vaginal Ring

8. Hormonal Contraceptives Market, by End-user

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Gynecology Centers
  • 8.4. Homecare
  • 8.5. Hospitals & Clinics

9. Americas Hormonal Contraceptives Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Hormonal Contraceptives Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Hormonal Contraceptives Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Afaxys Pharma, LLC
  • 2. Agile Therapeutics
  • 3. Amgen Inc.
  • 4. Bayer AG
  • 5. Boehringer Ingelheim GmbH
  • 6. Cipla Limited
  • 7. Glenmark Pharmaceuticals Limited
  • 8. HLL Lifecare Limited
  • 9. Johnson & Johnson Services, Inc.
  • 10. Lupin Pharmaceuticals, Inc.
  • 11. Novartis AG
  • 12. Pfizer, Inc.
  • 13. Piramal Group
  • 14. Sun Pharmaceutical Industries Ltd.
  • 15. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. HORMONAL CONTRACEPTIVES MARKET RESEARCH PROCESS
  • FIGURE 2. HORMONAL CONTRACEPTIVES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HORMONAL CONTRACEPTIVES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HORMONAL CONTRACEPTIVES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HORMONAL CONTRACEPTIVES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HORMONAL CONTRACEPTIVES MARKET DYNAMICS
  • TABLE 7. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANDROGENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANTIANDROGENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ESTROGENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GONADOTROPINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY PROGESTOGENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTED CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTED CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INTRAUTERINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GYNECOLOGY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 67. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 70. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 73. SINGAPORE HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 76. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 79. TAIWAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 82. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 85. VIETNAM HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 92. DENMARK HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 95. EGYPT HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 98. FINLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 101. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 104. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 107. ISRAEL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 110. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 113. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 116. NIGERIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 119. NORWAY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 122. POLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 125. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 128. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 131. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 137. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 140. SWEDEN HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 143. SWITZERLAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 146. TURKEY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. HORMONAL CONTRACEPTIVES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 154. HORMONAL CONTRACEPTIVES MARKET, FPNV POSITIONING MATRIX, 2023